VecTech
Techstars '23Baltimore, US · 1 known investors
Vectech develops AI-powered vector identification and surveillance technologies to support public health interventions and targeted mosquito control during disease outbreaks. The company serves public health organizations and disease prevention agencies globally.
Founders & leadership
TF
Tristan FordCo-founder + CEO
MG
Meg GlanceyCo-founder + Advisor
AG
Autumn GoodwinCo-founder + Chief Technology Officer
Investors · 1
Competitors · 3
by search overlapDiabetes Prevention Program9 shared keywords
Cornell3 shared keywordsCornell University is a university in New York conducting research and education across fields including health, climate, agriculture, and technology.
Idx3 shared keywords
Companies competing with VecTech for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase II | 2023 | $2M |
| National Science Foundation | Phase II | 2023 | $999.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $950.4K |
| Department of Agriculture (USDA) | Phase II | 2022 | $649.8K |
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2022 | $298.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $350.7K |
| National Science Foundation | Phase I | 2021 | $255.8K |
| Department of Agriculture (USDA) | Phase I | 2021 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.